Envestnet Portfolio Solutions Inc. Lowers Stock Position in The Cooper Companies, Inc. (NASDAQ:COO)

Envestnet Portfolio Solutions Inc. cut its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 5.3% in the fourth quarter, Holdings Channel.com reports. The fund owned 32,336 shares of the medical device company’s stock after selling 1,818 shares during the period. Envestnet Portfolio Solutions Inc.’s holdings in Cooper Companies were worth $2,973,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in COO. Fulton Bank N.A. boosted its holdings in Cooper Companies by 3.0% during the 4th quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company’s stock valued at $342,000 after acquiring an additional 109 shares during the period. Torray Investment Partners LLC lifted its position in shares of Cooper Companies by 0.8% during the fourth quarter. Torray Investment Partners LLC now owns 16,190 shares of the medical device company’s stock worth $1,488,000 after purchasing an additional 132 shares in the last quarter. Mather Group LLC. lifted its position in shares of Cooper Companies by 7.4% during the fourth quarter. Mather Group LLC. now owns 1,926 shares of the medical device company’s stock worth $177,000 after purchasing an additional 133 shares in the last quarter. MassMutual Private Wealth & Trust FSB boosted its stake in shares of Cooper Companies by 15.6% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,008 shares of the medical device company’s stock valued at $93,000 after purchasing an additional 136 shares during the period. Finally, Greenleaf Trust grew its holdings in shares of Cooper Companies by 5.0% in the fourth quarter. Greenleaf Trust now owns 2,915 shares of the medical device company’s stock valued at $268,000 after purchasing an additional 139 shares in the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on COO shares. Robert W. Baird reduced their target price on shares of Cooper Companies from $117.00 to $107.00 and set an “outperform” rating on the stock in a report on Friday, March 7th. JPMorgan Chase & Co. reduced their price objective on Cooper Companies from $120.00 to $110.00 and set an “overweight” rating on the stock in a research note on Friday, March 7th. Citigroup lowered their target price on Cooper Companies from $115.00 to $110.00 and set a “buy” rating for the company in a research note on Friday, March 7th. Morgan Stanley reduced their price target on Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research report on Friday, December 6th. Finally, BNP Paribas upgraded Cooper Companies to a “hold” rating in a research note on Thursday, March 13th. Four analysts have rated the stock with a hold rating and seven have given a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $110.25.

Cooper Companies Trading Up 0.1 %

COO opened at $80.12 on Thursday. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The Cooper Companies, Inc. has a one year low of $77.05 and a one year high of $112.38. The company has a market cap of $16.02 billion, a P/E ratio of 41.09, a PEG ratio of 2.25 and a beta of 1.02. The business’s 50-day simple moving average is $90.45 and its 200-day simple moving average is $98.44.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, meeting the consensus estimate of $0.92. The company had revenue of $964.70 million for the quarter, compared to analyst estimates of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. As a group, equities research analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.